Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marland, G.
Right arrow Articles by Figdor, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marland, G.
Right arrow Articles by Figdor, C. G.
Stem Cells, Vol. 14, No. 5, 501-507, September 1996
© 1996 AlphaMed Press


CONCISE REVIEW

Dendritic Cells in Immune Response Induction

Gill Marland, Alexander B. Bakker, Gosse J. Adema, Carl G. Figdor

Department of Tumor Immunology, University Hospital Nijmegen, The Netherlands

Key Words. Dendritic cell • Antigen-presenting cell • Primary immune response • T lymphocyte • Antitumor • MHC class I • MHC class II

Correspondence: Dr. Gill Marland, Department of Tumor Immunology, University Hospital Nijmegen, Philips van Leydenlaan 25, 6525 EX Nijmegen, The Netherlands.

The study of dendritic cells (DCs) has seen a rapid expansion in recent years, and their importance within the immune system is now widely recognized. Along with B lymphocytes and mononuclear phagocytes, DCs make up what are known as the professional antigen-presenting cells (APCs). These are cells which are capable of highly efficiently presenting antigens to the immune system in the context of both major histocompatibility complex class I and class II molecules. What makes DCs stand out from other professional APCs, however, is their seemingly unique ability to present antigen to T lymphocytes which have had no previous contact with antigen. This gives DCs a central role in the initiation of immune responses, and creates possibilities for their exploitation in the development of therapeutic strategies against tumors and other diseases.

What are the characteristics of DCs which enable them to carry out their specialized function? This is a question which is currently gaining much interest. While higher expression levels of the antigen-presentation machinery may account for this, there may also be as yet unidentified mechanisms at work. In this review, we will discuss the evidence for DC-mediated priming of both CD4+ and CD8+ naive T cells, both in vitro and in vivo, current ideas on how DCs achieve their potent function and the implications for the design and execution of immunotherapeutic strategies.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
S. He, Q. Cao, H. Yoneyama, H. Ge, Y. Zhang, and Y. Zhang
MIP-3{alpha} and MIP-1{alpha} rapidly mobilize dendritic cell precursors into the peripheral blood
J. Leukoc. Biol., December 1, 2008; 84(6): 1549 - 1556.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Morrow, B. Slobedman, A. L. Cunningham, and A. Abendroth
Varicella-Zoster Virus Productively Infects Mature Dendritic Cells and Alters Their Immune Function
J. Virol., April 15, 2003; 77(8): 4950 - 4959.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Abendroth, G. Morrow, A. L. Cunningham, and B. Slobedman
Varicella-Zoster Virus Infection of Human Dendritic Cells and Transmission to T Cells: Implications for Virus Dissemination in the Host
J. Virol., July 1, 2001; 75(13): 6183 - 6192.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. E. Jenkins, L. L. Yasukawa, R. Bergen, C. Benike, E. G. Engleman, and A. M. Arvin
Comparison of Primary Sensitization of Naive Human T Cells to Varicella-Zoster Virus Peptides by Dendritic Cells In Vitro with Responses Elicited In Vivo by Varicella Vaccination
J. Immunol., January 1, 1999; 162(1): 560 - 567.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yanagihara, E. Komura, J. Nagafune, H. Watarai, and Y. Yamaguchi
EBI1/CCR7 Is a New Member of Dendritic Cell Chemokine Receptor That Is Up-Regulated upon Maturation
J. Immunol., September 15, 1998; 161(6): 3096 - 3102.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 1996 by AlphaMed Press.